The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats.

Abstract

Recombinant human GM-CSF (rhGM-CSF) and erythropoietin (rhEPO) were tested on chronically FIV-infected laboratory cats and uninfected specific-pathogen-free (SPF) cats. In Study 1, a total of eight cats (four cats per group of either infected or uninfected cats) received subcutaneous injection (twice a day) for 2 weeks with 5 microg/kg of rhGM-CSF, while… (More)

Topics

Cite this paper

@article{Arai2000TheUO, title={The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats.}, author={Makoto Arai and Jacques Darman and Amanda L Lewis and Janet K. Yamamoto}, journal={Veterinary immunology and immunopathology}, year={2000}, volume={77 1-2}, pages={71-92} }